Company intelligence / Profile preview

tilibit nanosystems

Munich/Obersendling, Bayern/Bavaria, Germanytilibit.com ↗

Ownership: Private
Employees: ~30
Development stage: Commercial

Overview

Tilibit nanosystems provides high-quality scaffold ssDNA and ready-to-use DNA origami kits globally. Their products are used in advanced research across healthcare, materials science, diagnostics, nanoelectronics, nanopore sequencing, and targeted drug delivery. The company collaborates with Nanogami GmbH to accelerate next-generation nanotechnology development. No direct clinical results as they are a technology/materials provider.

Therapeutic areas: Other
Modalities: DNA origami structuresScaffold single-stranded DNA (ssDNA)Custom nanostructures for drug delivery and nanoelectronics
Industry: Non-Drug Biotech

Partnerships

Nanogami GmbH – strategic partnership since at least 2022 focused on advancing the field of DNA origami with support from SPRIN-D funding.

Beyond the preview

Go deeper on tilibit nanosystems.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on tilibit nanosystems.

Explore the full profile